82 related articles for article (PubMed ID: 22834706)
1. ³²P-chromic phosphate-Poly(L-Lactide) seeds of sustained release and their brachytherapy for prostate cancer with lymphatic metastasis.
He X; Jia R; Xu L; Liang K; Wang Z; Shao G; Huang P; Li W
Cancer Biother Radiopharm; 2012 Sep; 27(7):446-51. PubMed ID: 22834706
[TBL] [Abstract][Full Text] [Related]
2. [Implantation brachytherapy with 32P-chromic phosphate-poly (L-lactide) delayed-release particles for prostate cancer in nude mice].
He XJ; Jia RP; Shao GQ; Xu LW; Wang ZZ; Huang PL; Wu JP; Wang J
Zhonghua Nan Ke Xue; 2010 Oct; 16(10):872-6. PubMed ID: 21243748
[TBL] [Abstract][Full Text] [Related]
3. Antitumor effects of
Sun L; Zhu X; Xu L; Wang Z; Shao G; Zhao J
Oncol Lett; 2013 Sep; 6(3):687-692. PubMed ID: 24137391
[TBL] [Abstract][Full Text] [Related]
4. Investigation of Newly Prepared Biodegradable
Shao G; Wang Y; Liu X; Zhao M; Song J; Huang P; Wang F; Wang Z
Contrast Media Mol Imaging; 2018; 2018():2630480. PubMed ID: 29853804
[No Abstract] [Full Text] [Related]
5. Preliminary study of the biodegradation and the correlation between in vitro and in vivo release of (32)P-chromic phosphate-poly(L-lactide) seeds.
Zhao J; Du G; Su Y; Shao G; Wang Z; Xu L
Cancer Biother Radiopharm; 2013 Dec; 28(10):703-8. PubMed ID: 23806021
[TBL] [Abstract][Full Text] [Related]
6. [Experimental study of CT guided ³²P-CP-PLLA microparticle implantation in the treatment of rabbit VX2 lung tumor].
Pan D; Yang M; Xu Y; Wang L; Liu L; Huang P
Zhongguo Fei Ai Za Zhi; 2011 Jan; 14(1):1-6. PubMed ID: 21219823
[TBL] [Abstract][Full Text] [Related]
7. Intratumoral injection of 32P-chromic phosphate in the treatment of implanted pancreatic carcinoma.
Gao W; Liu L; Liu ZY; Wang Y; Jiang B; Liu XN
Cancer Biother Radiopharm; 2010 Apr; 25(2):215-24. PubMed ID: 20423235
[TBL] [Abstract][Full Text] [Related]
8. Safety evaluation of 32P-chromic phosphate-poly L lactic acid particles interstitially implanted into livers of Beagle dogs.
Liu L; Huang P; Nie Q; Qi B; Wu Q; Gao H; Yang Z; Chen D
Cancer Biother Radiopharm; 2012 Mar; 27(2):156-63. PubMed ID: 22316174
[TBL] [Abstract][Full Text] [Related]
9. Bioevaluation study of 32P-CP-PLLA particle brachytherapy in a rabbit VX2 lung tumor model.
Xu Yp; Yang M; Pan Dh; Wang Lz; Liu L; Huang P; Shao G
Appl Radiat Isot; 2012 Apr; 70(4):583-8. PubMed ID: 22245365
[TBL] [Abstract][Full Text] [Related]
10. Chromic-P32 phosphate treatment of implanted pancreatic carcinoma: mechanism involved.
Liu L; Feng GS; Gao H; Tong GS; Wang Y; Gao W; Huang Y; Li C
World J Gastroenterol; 2005 Apr; 11(14):2101-8. PubMed ID: 15810075
[TBL] [Abstract][Full Text] [Related]
11. Preventing and treating lymphatic minute metastasis with (32)p-chromic phosphate during an operation.
Daozhen C; Lu L; Guansheng T; Zhiyong L; Xudong L; Ying H
Cancer Biother Radiopharm; 2007 Feb; 22(1):24-32. PubMed ID: 17461726
[TBL] [Abstract][Full Text] [Related]
12. Brachytherapy with Intratumoral Injections of Radiometal-Labeled Polymers That Thermoresponsively Self-Aggregate in Tumor Tissues.
Sano K; Kanada Y; Kanazaki K; Ding N; Ono M; Saji H
J Nucl Med; 2017 Sep; 58(9):1380-1385. PubMed ID: 28408533
[TBL] [Abstract][Full Text] [Related]
13. Low-Dose Prostate Cancer Brachytherapy with Radioactive Palladium-Gold Nanoparticles.
Laprise-Pelletier M; Lagueux J; Côté MF; LaGrange T; Fortin MA
Adv Healthc Mater; 2017 Feb; 6(4):. PubMed ID: 28116855
[TBL] [Abstract][Full Text] [Related]
14. Novel lactoferrin-conjugated amphiphilic poly(aminoethyl ethylene phosphate)/poly(L-lactide) copolymer nanobubbles for tumor-targeting ultrasonic imaging.
Luo B; Liang H; Zhang S; Qin X; Liu X; Liu W; Zeng F; Wu Y; Yang X
Int J Nanomedicine; 2015; 10():5805-17. PubMed ID: 26396514
[TBL] [Abstract][Full Text] [Related]
15. Complete tumor response following intratumoral 32P BioSilicon on human hepatocellular and pancreatic carcinoma xenografts in nude mice.
Zhang K; Loong SL; Connor S; Yu SW; Tan SY; Ng RT; Lee KM; Canham L; Chow PK
Clin Cancer Res; 2005 Oct; 11(20):7532-7. PubMed ID: 16243828
[TBL] [Abstract][Full Text] [Related]
16. Interstitial injection of (32)P-chromic phosphate during lung cancer resection to treat occult lymphatic metastasis.
Gao W; Liu L; Liu ZY; Li XD; Li C
Nucl Med Commun; 2009 Jun; 30(6):420-6. PubMed ID: 19398935
[TBL] [Abstract][Full Text] [Related]
17. Systemic interleukin 2 therapy for human prostate tumors in a nude mouse model.
Triest JA; Grignon DJ; Cher ML; Kocheril SV; Montecillo EJ; Talati B; Tekyi-Mensah S; Pontes JE; Hillman GG
Clin Cancer Res; 1998 Aug; 4(8):2009-14. PubMed ID: 9717832
[TBL] [Abstract][Full Text] [Related]
18. Tissue reactions to engineered cartilage based on poly-L-lactic acid scaffolds.
Fujihara Y; Asawa Y; Takato T; Hoshi K
Tissue Eng Part A; 2009 Jul; 15(7):1565-77. PubMed ID: 19115823
[TBL] [Abstract][Full Text] [Related]
19. The preparation and characterization of anti-VEGFR2 conjugated, paclitaxel-loaded PLLA or PLGA microspheres for the systemic targeting of human prostate tumors.
Lu J; Jackson JK; Gleave ME; Burt HM
Cancer Chemother Pharmacol; 2008 May; 61(6):997-1005. PubMed ID: 17701176
[TBL] [Abstract][Full Text] [Related]
20. Imaging prostate cancer lymph node metastases with a multimodality contrast agent.
Hall MA; Kwon S; Robinson H; Lachance PA; Azhdarinia A; Ranganathan R; Price RE; Chan W; Sevick-Muraca EM
Prostate; 2012 Feb; 72(2):129-46. PubMed ID: 21538422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
